Acinetobacter Infections Treatment Market: Increasing Incidence Rate of Hospital Acquired Bacterial Infections Fueling the Growth of the Market
Obtain Report Details @ http://www.transparencymarketresearch.com/acinetobacter-infections-treatment-market.html
Acinetobacter is inherently multidrug resistant. However, some of the drugs to which Acinetobacter is sensitive are as follows:
Some of the drug molecules in the pipeline that has the potential to become a blockbuster product in the future are as follows:
-EV-035 – a topoisomerase inhibitor based on novel 2-pyridone with broad spectrum activity
-ACHN-978 – a promising aminoglycoside anti-bacterial drug developed by Achaogen, Inc.
-NAB-739 – a novel polymyxin derivative effective against gram-negative pathogens
The primary factors fuelling the growth of the acinetobacter infections treatment market are increasing incidence rate of hospital acquired bacterial infections and introduction of novel therapeutics that are safe and highly effective. Moreover, development of personalized medicines designed specifically according to the genetic composition of an individual is also expected to drive this market to a certain extent. It is also expected that introduction of innovative infection control devices and products, that are cost-effective would help in the market size expansion of the overall acinetobacter infections treatment market.
Furthermore, increasing incidence rate of traumatic injuries is also expected to drive the market growth of acinetobacter infections treatment market. Additionally, market-restraining factor that might hamper the growth of the market is development of resistance against anti-bacterial drugs, which makes existing antibacterial drugs archaic in certain circumstances. Moreover, product safety concerns, availability and effectiveness of these products are some of the factors that might considerably affect the sales and growth of the acinetobacter infections treatment market.
Geographically, North America is the leading market for acinetobacter infections treatment market. Due to the stringent hospital regulatory policies and increased government support for controlling and preventing hospital acquired acinetobacter infections, this region is able to maintain its dominant position globally. Europe closely follows North America in terms of growth, due to increasing incidence of hospital acquired bacterial infections.
Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16991
According to the Health Protection Agency (HPA), in England, most of patients admitted in hospitals acquire some form of bacterial infection during their hospital stay. However, other regions such as South East Asia, Middle East and Latin America are expected to be the promising markets in the near future. Owing to the rising disposable income among population, increasing incidence of bacterial infections and developing healthcare infrastructure, these regions are expected to be the potential market in the near future.
Currently, the acinetobacter infections treatment market is highly fragmented due to the involvement of many established and emerging generic drug manufacturers. Few of the companies associated with the development and commercialization of drugs for treating acinetobacter infections are Achaogen, Inc., Ancalima Lifesciences Ltd., AmpliPhi Biosciences Corporation, AVI BioPharma Inc., Cantab Biopharmaceuticals Limited, Evolva Holding SA, Novabiotics Ltd., Pfizer, Inc., Sarepta Therapeutics, Inc., Synthetic Biologics, Inc., Trana Discovery, Inc., Vaxdyn, S.L.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acinetobacter Infections Treatment Market: Increasing Incidence Rate of Hospital Acquired Bacterial Infections Fueling the Growth of the Market here
News-ID: 562191 • Views: 147
More Releases from Transparency Market Research
Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the
More Releases for Acinetobacter
Global Acinetobacter Infections Treatment Market 2019 - Entasis Therapeutics, Ro …
The global "Acinetobacter Infections Treatment Market" report delivers a comprehensive and systematic framework of the Acinetobacter Infections Treatment market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Acinetobacter Infections Treatment market and the research team meticulously analyze the gathered data with the help of various analytical tools and present their opinion based on analysis
Global Acinetobacter Infections Treatment Market Study by Leading Player, Resear …
An up-to-date research report 2018 has been disclosed by Market Research Hub highlighting the title “Global Acinetobacter Infections Treatment Market Report 2018” which provides an outlook for current market value as well as the expected forecast including Rate on Investment (ROI) together with the growing CAGR near XX% during 2018-2025. The report studies the Acinetobacter Infections Treatment market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India,
United States Acinetobacter Infections Treatment Market Overview And Forecasts 2 …
Qyresearchreports include new market research report "United States Acinetobacter Infections Treatment Market Report 2018" to its huge collection of research reports. The United States Acinetobacter Infections Treatment market has been meticulously researched on and studied and detailed on in this publication with the help of advanced primary and secondary research that has been performed by the best of analysts and using the best of the available techniques. The publications that enable
Acinetobacter Infections Treatment Market Share and Forecasts Research Report 20 …
Acinetobacter Infections Treatment market get comprehensive research offering detailed regional analysis and growth outlook in a new report now available at MarketStudyReport.com An inherent sub-vertical of the Healthcare industry space, Acinetobacter Infections Treatment Market stands to gain remarkable proceeds over 2018-2023, as per a recently compiled report. Covering the pivotal geographies of the Asia Pacific, Middle East and Africa (MEA), South America, North America, and Europe, this report minutely categorizes global
Acinetobacter Infections Treatment Market - Global Industry Analysis and Forecas …
Global Acinetobacter Infections Treatment Market: Overview Acinetobacter baumannii is a rod shaped gram-negative coccobacillus bacterium. This bacterium is becoming an important cause of hospital derived bacterial infection affecting people with weakened immune system. Acinetobacter infections usually affect organ systems, which have a high content of fluid (e.g. peritoneal fluid, respiratory tract, urinary tract, cerebrospinal fluid etc.) leading to infections related to continuous ambulatory peritoneal dialysis and nocosomial pneumonia. At present, acinetobacter
Acinetobacter Infections Treatment Market with Worldwide Industry Analysis to 20 …
Global Acinetobacter Infections Treatment Market: Overview Acinetobacter baumannii is a rod shaped gram-negative coccobacillus bacterium. This bacterium is becoming an important cause of hospital derived bacterial infection affecting people with weakened immune system. Acinetobacter infections usually affect organ systems, which have a high content of fluid (e.g. peritoneal fluid, respiratory tract, urinary tract, cerebrospinal fluid etc.) leading to infections related to continuous ambulatory peritoneal dialysis and nocosomial pneumonia. At present,